易明医药：拟授予激励对象的限制性股票数量为340.38万股

Group 1 - The core point of the article is that 易明医药 announced a restricted stock incentive plan involving the grant of 3.4038 million shares to 26 individuals [1] - The incentive plan will utilize shares repurchased from the secondary market, specifically RMB A-shares [1] - The announcement was made on February 11, indicating a strategic move to motivate and retain key personnel within the company [1]